These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 34386070)

  • 1. Upregulation of CENPF is linked to aggressive features of osteosarcoma.
    Zou PA; Yang ZX; Wang X; Tao ZW
    Oncol Lett; 2021 Sep; 22(3):648. PubMed ID: 34386070
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Overexpression of CENPF is associated with progression and poor prognosis of lung adenocarcinoma.
    Li MX; Zhang MY; Dong HH; Li AJ; Teng HF; Liu AL; Xu N; Qu YQ
    Int J Med Sci; 2021; 18(2):494-504. PubMed ID: 33390818
    [No Abstract]   [Full Text] [Related]  

  • 3. CENPF promotes papillary thyroid cancer progression by mediating cell proliferation and apoptosis.
    Han Y; Xu S; Cheng K; Diao C; Liu S; Zou W; Bi Y
    Exp Ther Med; 2021 Apr; 21(4):401. PubMed ID: 33680123
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enhanced expression of centromere protein F predicts clinical progression and prognosis in patients with prostate cancer.
    Zhuo YJ; Xi M; Wan YP; Hua W; Liu YL; Wan S; Zhou YL; Luo HW; Wu SL; Zhong WD; Wu CL
    Int J Mol Med; 2015 Apr; 35(4):966-72. PubMed ID: 25647485
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Upregulation of centromere protein F is linked to aggressive prostate cancers.
    Göbel C; Özden C; Schroeder C; Hube-Magg C; Kluth M; Möller-Koop C; Neubauer E; Hinsch A; Jacobsen F; Simon R; Sauter G; Michl U; Pehrke D; Huland H; Graefen M; Schlomm T; Luebke AM
    Cancer Manag Res; 2018; 10():5491-5504. PubMed ID: 30519097
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cell Cycle-Related Centromere Protein F Deficiency Suppresses Ovarian Cancer Cell Growth by Inducing Ferroptosis.
    Liu X; Guo L; Suo Y; Tang X; Zhu T; Zhao T; Zhang W; Zhang P
    Gynecol Obstet Invest; 2024 May; ():1-13. PubMed ID: 38723616
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of potential key genes and functional role of CENPF in osteosarcoma using bioinformatics and experimental analysis.
    Ma Y; Guo J; Li D; Cai X
    Exp Ther Med; 2022 Jan; 23(1):80. PubMed ID: 34934449
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Integrated pan-cancer analysis of centromere protein F and experimental verification of its role and clinical significance in cholangiocarcinoma.
    Cao Z; Zeng L; Wang Z; Wen X; Zhang J
    Funct Integr Genomics; 2023 May; 23(2):190. PubMed ID: 37247093
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Centromere Protein F (
    Huang Y; Chen X; Wang L; Wang T; Tang X; Su X
    J Cancer; 2021; 12(10):2933-2951. PubMed ID: 33854594
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Centromere protein F promotes progression of hepatocellular carcinoma through ERK and cell cycle-associated pathways.
    Chen H; Wu F; Xu H; Wei G; Ding M; Xu F; Deivasigamani A; Zhou G; Hui KM; Xia H
    Cancer Gene Ther; 2022 Jul; 29(7):1033-1042. PubMed ID: 34857915
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CENPF/CDK1 signaling pathway enhances the progression of adrenocortical carcinoma by regulating the G2/M-phase cell cycle.
    Huang YG; Li D; Wang L; Su XM; Tang XB
    J Transl Med; 2022 Feb; 20(1):78. PubMed ID: 35123514
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of the oncogenic function of centromere protein F in hepatocellular carcinoma.
    Dai Y; Liu L; Zeng T; Zhu YH; Li J; Chen L; Li Y; Yuan YF; Ma S; Guan XY
    Biochem Biophys Res Commun; 2013 Jul; 436(4):711-8. PubMed ID: 23791740
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cell-Cycle-related Protein Centromere Protein F Deficiency Inhibits Cervical Cancer Cell Growth by Inducing Ferroptosis Via Nrf2 Inactivation.
    Tang XH; Zhao TN; Guo L; Liu XY; Zhang WN; Zhang P
    Cell Biochem Biophys; 2024 Mar; ():. PubMed ID: 38536579
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CENPF as an independent prognostic and metastasis biomarker corresponding to CD4+ memory T cells in cutaneous melanoma.
    Li M; Zhao J; Yang R; Cai R; Liu X; Xie J; Shu B; Qi S
    Cancer Sci; 2022 Apr; 113(4):1220-1234. PubMed ID: 35189004
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CENPF promotes the proliferation of renal cell carcinoma
    Zhang J; Wang Z; Liu Z; Chen Z; Jiang J; Ji Y; Zhang Y; Zhu H; Zheng B
    Transl Androl Urol; 2023 Feb; 12(2):320-329. PubMed ID: 36915885
    [TBL] [Abstract][Full Text] [Related]  

  • 16. LRIG2 regulates cell proliferation, migration and apoptosis of osteosarcoma.
    Li ZQ; Liao WJ; Sun BL; Luo ZW; Zhong NS; Wu JB; Liu ZL; Liu JM
    BMC Cancer; 2022 Oct; 22(1):1029. PubMed ID: 36183058
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CircDLG1 promotes malignant development of non-small cell lung cancer through regulation of the miR-630/CENPF axis.
    Chen Y; Zhang Y
    Strahlenther Onkol; 2023 Feb; 199(2):169-181. PubMed ID: 35748916
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Centromere protein F (CENPF), a microtubule binding protein, modulates cancer metabolism by regulating pyruvate kinase M2 phosphorylation signaling.
    Shahid M; Lee MY; Piplani H; Andres AM; Zhou B; Yeon A; Kim M; Kim HL; Kim J
    Cell Cycle; 2018; 17(24):2802-2818. PubMed ID: 30526248
    [TBL] [Abstract][Full Text] [Related]  

  • 19. NLRP3 Overexpression Associated With Poor Prognosis and Presented as an Effective Therapeutic Target in Osteosarcoma.
    Huang Z; Chen H; Wang S; Wei H; Wang X; Shen R; Wang Y; Lin R; Lin J
    Front Pharmacol; 2021; 12():724923. PubMed ID: 34393801
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CBX3 predicts an unfavorable prognosis and promotes tumorigenesis in osteosarcoma.
    Ma C; Nie XG; Wang YL; Liu XH; Liang X; Zhou QL; Wu DP
    Mol Med Rep; 2019 May; 19(5):4205-4212. PubMed ID: 30942427
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.